Valmont Releases Sustainability Report
Shares in Valmont Industries, Inc. (NYSE: VMI), purporting to be a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity, today released its 2025 Sustainability Report. The report highlights Valmont’s ongoing commitment to operational efficiency, innovation, and environmental responsibility. It also outlines key initiatives that support resilient infrastructure, water conservation in agriculture, and employee well-being."At Valmont, sustainability is inherent to the way we operate," said CEO Avner Applbaum. “Every day, our 11,000 employees bring energy to our purpose of Conserving Resources. Improving Life®. This report showcases their dedication and the real-world outcomes we are achieving around the globe."The 2025 report highlights several key efforts, including: Product case studies which demonstrate the company’s role in building stronger, more resilient infrastructure and enhancing food security through irrigation.Also featured are exceptional grassroots sustainability efforts across the organization, including recognition of the Valmont team in Charmeil, France for their advancements.The company also points out notable improvements in 2024 safety metrics and a strong focus on codifying a safety-first culture.Completion of the Project 90/90 initiative, converting 90% of manufacturing facilities to 90% LED lighting.VMI shares ended trading Thursday at $325.15.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


